Ringwood, Australia

Geoffrey A Pietersz

This inventor holds 1 USPTO granted patent. Top assignee: Consolidated Pharmaceuticals, Limited. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey A Pietersz. Retrieved from https://idiyas.com/inventor/geoffrey-a-pietersz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Geoffrey A. Pietersz

Introduction

Geoffrey A. Pietersz is an accomplished inventor based in Ringwood, Australia, recognized for his significant contributions to the field of pharmaceuticals. With a focus on advancing medical treatments, he has developed innovations that aim to improve patient outcomes and therapeutic efficacy.

Latest Patents

Among his notable achievements, Geoffrey holds a patent for Melphalan derivatives. This innovation contributes to enhanced variations of Melphalan, a chemotherapeutic agent, allowing for more effective treatment options in cancer therapy.

Career Highlights

Geoffrey is associated with Consolidated Pharmaceuticals Limited, where he plays a vital role in research and development. His work at the company reflects his commitment to pharmaceutical innovation, showcasing his ability to translate complex scientific concepts into practical applications that aid in patient care.

Collaborations

Throughout his career, Geoffrey has collaborated with notable professionals, including Ian F. McKenzie and Mark Smyth. These collaborations have been instrumental in advancing his research endeavors, fostering a productive environment for innovation within the pharmaceutical industry.

Conclusion

Geoffrey A. Pietersz exemplifies the spirit of innovation in the pharmaceutical sector. His contributions, particularly in the development of Melphalan derivatives, underline his dedication to improving healthcare solutions. As he continues his work at Consolidated Pharmaceuticals Limited, his future efforts are eagerly anticipated within the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…